Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA9 | Q16790 | 3/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.32 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL806005 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL11597307 | 0.90 | CYP1A2 (0.43) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL24928933 | 0.86 | CYP1A2 (0.37) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL16299314 | 0.86 | CYP1A2 (0.37) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL19368344 | 0.86 | TSHR (0.38) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL14328669 | 0.84 | CYP1A2 (0.40) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL173217 | 0.84 | CYP1A2 (0.40) | CYP1A2MAPK1CA12CA1CA2 | |
| SCHEMBL7965098 | 0.82 | — | — | |
| SCHEMBL7965094 | 0.82 | — | — | |
| SCHEMBL9289906 | 0.82 | CYP1A2 (0.44) | CYP1A2MAPK1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 379 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11021499-B2 | Bis(6-methyl-3-sulphophenyl)(2-methylphenyl)phosphine, ammonium salt thereof, and method for producing same | KURARAY CO., LTD. (JP) | 2021-06-01 | — | — | US | claimed |
| CN-108623577-B | Preparation method of amonebvir and intermediate thereof | 山东百诺医药股份有限公司 | 2020-09-25 | — | — | CN | claimed |
| US-10696701-B2 | Bis(6-methyl-3-sulphophenyl)phenylphosphine, ammonium salt thereof, and method for producing same | KURARAY CO., LTD. (JP) | 2020-06-30 | — | — | US | claimed |
| US-20190071460-A1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | HONDA ERIKO (JP) | 2019-03-07 | — | — | US | claimed |
| EP-2980093-B1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2019-01-09 | — | — | EP | claimed |
| US-20180141967-A1 | BIS(6-METHYL-3-SULPHOPHENYL)PHENYLPHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO., LTD. (JP) | 2018-05-24 | — | — | US | claimed |
| EP-2980092-B1 | BIS(6-METHYL-3-SULPHOPHENYL)PHENYLPHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO (JP) | 2017-10-04 | — | — | EP | claimed |
| US-20160052948-A1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO., LTD. (JP) | 2016-02-25 | — | — | US | claimed |
| US-20160052947-A1 | BIS(6-METHYL-3-SULPHOPHENYL)PHENYLPHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | KURARAY CO., LTD. (JP) | 2016-02-25 | — | — | US | claimed |
| EP-2980093-A1 | BIS(6-METHYL-3-SULPHOPHENYL)(2-METHYLPHENYL)PHOSPHINE, AMMONIUM SALT THEREOF, AND METHOD FOR PRODUCING SAME | Kuraray Co., Ltd. (JP) | 2016-02-03 | — | — | EP | claimed |
| EP-1484334-A2 | Process for producing phosphite | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-12-08 | — | — | EP | claimed |
| US-20040225145-A1 | Process for producing phosphite | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-11-11 | — | — | US | claimed |
| US-20030105353-A1 | Process for the arylation of olefins | LANXESS DEUTSCHLAND GMBH (DE) | 2003-06-05 | — | — | US | claimed |
| EP-0463922-A1 | Process for the esterification of carboxylic acids | RHONE-POULENC CHIMIE (FR) | 1992-01-02 | — | — | EP | claimed |
| EP-0138669-B1 | PROCESS FOR THE PREPARATION OF SILANES FROM METHYLDICHLOROSILANE AND CHLOROSILANES | RHONE-POULENC CHIMIE (FR) | 1988-08-10 | — | — | EP | claimed |
| EP-0138670-B1 | PROCESS FOR THE PREPARATION OF SILANES WITH A SI-H BOND BY REDISTRIBUTION | RHONE-POULENC CHIMIE (FR) | 1988-05-25 | — | — | EP | claimed |
| US-4746752-A | QUATERNARY OR TERTIARY AMINE CATALYST | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1988-05-24 | — | — | US | claimed |
| US-4605543-A | DISTRIBUTION AND DISPROPORTIONATION CATALYSIS | RHONE-POULENC SPECIALITIES CHIMIQUES (FR) | 1986-08-12 | — | — | US | claimed |
| EP-0138669-A2 | Process for the preparation of silanes from methyldichlorosilane and chlorosilanes | RHONE-POULENC CHIMIE (FR) | 1985-04-24 | — | — | EP | claimed |
| EP-0138670-A2 | Process for the preparation of silanes with a Si-H bond by redistribution | RHONE-POULENC CHIMIE (FR) | 1985-04-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105353-A1 | Process for the arylation of olefins | NEK6, JUN, AOC2 | CYP1A2 537/4885MAPK1 332/4885CA12 3742/4885 |
| US-20040225145-A1 | Process for producing phosphite | PHOSPHO1, PLCG1, PLCG2 | CYP1A2 2006/4885MAPK1 762/4885CA12 256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.